Transcription of Site Master File final EU
{{id}} {{{paragraph}}}
1 of 8 EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Public Health and Risk Assessment Pharmaceuticals Brussels, SANCO/C8/AM/sl/ares(2010)1064603 EudraLex The Rules Governing Medicinal Products in the European Union Volume 4 Good Manufacturing Practice Medicinal Products for Human and Veterinary Use Explanatory Notes on the preparation of a site Master File These notes are intended to provide guidance on the recommended content of the site Master File. A requirement for a site Master File is referred to in Chapter 4 of the GMP Guide. Status of the document: New Commission Europ enne, B-1049 Bruxelles / Europese Commissie, B-1049 Brussel - Belgium Telephone: (32-2) 299 11 11 1.
System) Number (a unique identification number provided by Dun & Bradstreet) of the site1 1.2 Authorised pharmaceutical manufacturing activities of the site. ... packaging material for aseptic processes, testing of starting raw-materials etc, should be presented in Appendix 4;
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}